Aquinox Pharmaceuticals' Series C Round

Aquinox Pharmaceuticals raised a round of funding on April 01, 2013.

Aquinox Pharmaceuticals engages in the discovery and development of first-in-class, small molecule therapeutics targeting SH2-containing inositol-5'-phosphatase (SHIP1) for the treatment of inflammato…

Articles about Aquinox Pharmaceuticals' Series C Round: